DEF 14AThe Ballot
Ultragenyx Pharmaceutical Inc. files DEF 14A
Filed Apr 27, 2018 · 8y ago · Accession 0001193125-18-136529
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- RARE
- CIK
- 1515673
- Form type
- DEF 14A
- Filing date
- Apr 27, 2018
- Report date
- Jun 19, 2018
- Document
- d556898ddef14a.htm
- Size
- 988 KB